Hyperinsulinemia and hyperfiltration in renal transplantation

Transplantation

Volumn 87, Issue 2, 2009, Pages 274-279

  Porrini, Esteban ^a   Bayes, Beatriz ^b   Diaz, Juan M ^c   Ibernon, Meritxell ^d   Benitez, Rocio ^e   Domínguez, Rosa ^f   Moreno, Juan Manuel ^g   Delgado, Patricia ^a   Lauzurica, Ricardo ^b   Silva, Irene ^c   Moreso, Francisco ^d   Lampreabe, Ildefonso ^e   Arias, Manuel ^f   Osuna, Antonio ^g   Torres, Armando ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c FUNDACIÓ PUIGVERT   (Spain)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e HOSPITAL DE CRUCES   (Spain)

^f HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^g HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

Glomerular hyperfiltration; Insulin resistance

Indexed keywords

BASILIXIMAB; CREATININE; CYCLOSPORIN A; DACLIZUMAB; INSULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT CODING; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE DRUG DOSE; AGED; BIOLOGICAL MODEL; BLOOD; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; HYPERINSULINISM; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RISK FACTOR; SPAIN; STATISTICAL MODEL; TIME;

ADULT; AGED; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; KIDNEY TRANSPLANTATION; LINEAR MODELS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SPAIN; TIME FACTORS;

EID: 59649102760     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318191a7d5     Document Type: Article

References (25)

1. Chen J, Munter P, Hamm L, et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 2003; 14: 469.
2. Oterdoom LH, de Vries AP, Gansevoort RT, et al. Fasting insulin modifies the relation between age and renal function. Nephrol Dial Transplant 2007; 22: 1587.
3. Kurella M, Lo J, Chertow G. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005; 16: 2134.
4. Porrini E, Delgado P, Bigo C, et al. Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation. Am J Kidney Dis 2006; 48: 134.
5. Safaridis P, Ruilope L. Insulin resistance, hyperinsulinemia and renal injury: Mechanisms and implications. Am J Nephrol 2006; 26: 232.
6. Fujita T. Insulin resistance and salt-sensitive hypertension inmetabolic syndrome. Nephrol Dial Transplant 2007; 11: 3102.
7. Dengel D, Goldberg A, Mayuga R, et al. Insulin resistance, elevated glomerular filtration fraction and renal injury. Hypertension 1996; 28: 127.
8. Perlstein T, Gerhard-Herman M, Hollenberg N, et al. Insulin induces renal vasodilatation, increases plasma renin activity and sensitizes the renal vasculature to angiotensin receptor blockade in healthy subjects. J Am Soc Nephrol 2003; 14: 469.
9. Thomson S, Vallon V, Ronald Blantz C. Kidney function in early diabetes: The tubular hypothesis of glomerular filtration. Am J Physiol Renal Physiol 2004; 286: F8.
10. Tomaszewski M, Charchar F, Maric C, et al. Glomerular Hyperfiltration: A new marker of metabolic risk. Kidney Intern 2007; 71: 816.
11. Porrini E, Moreno J, Osuna A, et al. Prediabetes in patients receiving tacrolimus in the first year after kidney transplantation: A prospective and multicenter study. Transplantation 2008; 85: 1133.
12. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005; 28: S37.
13. Mariat C, Alamartine E, Barthelemy J-C, et al. Assessing renal graft function in clinical trials: Can tests predicting glomerular filtration rate substitute for a reference method? Kidney Intern 2004; 65: 289.
14. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989; 45: 255.
15. Rennke HG. Pathology of glomerular hyperfiltration. In MitchW, Brenner b, Stein J, eds. The progressive nature of renal disease. Contemporary issues in nephrology, Vol. 14. New York, Chirchill-Livinstone 1986, pp 111.
16. Cusumano A, Bodkin N, Hansem B, et al. Glomerular hypertrophy is associated with hyperinsulinemia and precedes overt diabetes in aging rhesus monkeys. Am J Kidney Dis 2002; 40: 1075.
17. Pluvio C, de Pascale E, Pluvio M, et al. Renal hemodynamics in renal transplant recipients. The role of reduced kidney mass and cyclosporine administration. Transplantation 1996; 61: 733.
18. Brenner B, Cohen R,Mildford E. In renal transplantation, one size may not fit all. J Am Soc Nephrol 1992; 2: 162.
19. Giral M, Nguyen J, Karam G, et al. Impact of renal mass on the clinical outcome of kidney transplants. J Am Soc Nephrol 2005; 16: 261.
20. Poggio E, Hila S, Stephany S, et al. Donor kidney volume and outcomes following live donor kidney transplantation. Am J Transplant 2006; 6: 616.
21. Kasiske B, Snyder J, Gilbertson D. Inadequate donor size in cadaveric kidney transplantation. J Am Soc Nephrol 2002; 14: 2152.
22. Bosma R, Kwakernaak A, Homan van der Veide, et al. Body mass index and glomerular hyperfiltration in renal transplant recipients: Cross sectional analysis and long-term impact. Am J Transplant 2007; 7: 645.
23. Bagby S. Obesity-initiated metabolic syndrome and the kidney: A recipe for chronic kidney disease? J Am Soc Nephrol 2004; 15: 2775.
24. Reaven G. Importance of identifying the overweight patients who will benefit the most by losing weight. Ann Intern Med 2003; 138: 420.
25. Ferrannini E, Natali A, Bell P, et al. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest 1997; 100: 1166.